ArticleJCI insight2024

Engineered cytokine/antibody fusion proteins improve IL-2 delivery to pro-inflammatory cells and promote antitumor activity.

Elissa K Leonard et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.